Page last updated: 2024-10-25

diazoxide and Esophageal Achalasia

diazoxide has been researched along with Esophageal Achalasia in 1 studies

Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.

Esophageal Achalasia: A motility disorder of the ESOPHAGUS in which the LOWER ESOPHAGEAL SPHINCTER (near the CARDIA) fails to relax resulting in functional obstruction of the esophagus, and DYSPHAGIA. Achalasia is characterized by a grossly contorted and dilated esophagus (megaesophagus).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thondam, SK1
Nair, S1
Wile, D1
Gill, GV1

Other Studies

1 other study available for diazoxide and Esophageal Achalasia

ArticleYear
Diazoxide for the treatment of hypoglycaemic dumping syndrome.
    QJM : monthly journal of the Association of Physicians, 2013, Volume: 106, Issue:9

    Topics: Aged; Aged, 80 and over; Diazoxide; Dumping Syndrome; Esophageal Achalasia; Female; Humans; Hypoglyc

2013